Clinical PathologyPub Date : 2024-07-26eCollection Date: 2024-01-01DOI: 10.1177/2632010X241263054
Md Easin Mia, Mithu Howlader, Farzana Akter, Md Murad Hossain
{"title":"Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.","authors":"Md Easin Mia, Mithu Howlader, Farzana Akter, Md Murad Hossain","doi":"10.1177/2632010X241263054","DOIUrl":"10.1177/2632010X241263054","url":null,"abstract":"<p><p>The COVID-19 pandemic-led worldwide healthcare crisis necessitates prompt societal, ecological, and medical efforts to stop or reduce the rising number of fatalities. Numerous mRNA based vaccines and vaccines for viral vectors have been licensed for use in emergencies which showed 90% to 95% efficacy in preventing SARS-CoV-2 infection. However, safety issues, vaccine reluctance, and skepticism remain major concerns for making mass vaccination a successful approach to treat COVID-19. Hence, alternative therapeutics is needed for eradicating the global burden of COVID-19 from developed and low-resource countries. Repurposing current medications and drug candidates could be a more viable option for treating SARS-CoV-2 as these therapies have previously passed a number of significant checkpoints for drug development and patient care. Besides vaccines, this review focused on the potential usage of alternative therapeutic agents including antiviral, antiparasitic, and antibacterial drugs, protease inhibitors, neuraminidase inhibitors, and monoclonal antibodies that are currently undergoing preclinical and clinical investigations to assess their effectiveness and safety in the treatment of COVID-19. Among the repurposed drugs, remdesivir is considered as the most promising agent, while favipiravir, molnupiravir, paxlovid, and lopinavir/ritonavir exhibited improved therapeutic effects in terms of elimination of viruses. However, the outcomes of treatment with oseltamivir, umifenovir, disulfiram, teicoplanin, and ivermectin were not significant. It is noteworthy that combining multiple drugs as therapy showcases impressive effectiveness in managing individuals with COVID-19. Tocilizumab is presently employed for the treatment of patients who exhibit COVID-19-related pneumonia. Numerous antiviral drugs such as galidesivir, griffithsin, and thapsigargin are under clinical trials which could be promising for treating COVID-19 individuals with severe symptoms. Supportive treatment for patients of COVID-19 may involve the use of corticosteroids, convalescent plasma, stem cells, pooled antibodies, vitamins, and natural substances. This study provides an updated progress in SARS-CoV-2 medications and a crucial guide for inventing novel interventions against COVID-19.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241263054"},"PeriodicalIF":1.9,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282570/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PathologyPub Date : 2024-07-26eCollection Date: 2024-01-01DOI: 10.1177/2632010X241265857
Fareeha Adnan, Nazia Khursheed, Moiz Ahmed Khan, Nazia Parveen
{"title":"Safeguarding Accuracy: The Impact of Interventions on Reducing Blood Culture Contamination.","authors":"Fareeha Adnan, Nazia Khursheed, Moiz Ahmed Khan, Nazia Parveen","doi":"10.1177/2632010X241265857","DOIUrl":"10.1177/2632010X241265857","url":null,"abstract":"<p><strong>Introduction: </strong>Blood culture is the gold standard for diagnosing bacteremia and direct the physicians to select appropriate antimicrobials. In hospitals, blood culture contamination (BCC) is a common problem that has a detrimental effect on patient outcomes. Hence, we implemented strategies in our tertiary care setup, for training phlebotomists and nurses in proper blood sampling techniques, and assessed their effectiveness in reducing BCC rates.</p><p><strong>Methods: </strong>This interventional study was conducted at the Indus Hospital, Karachi, Pakistan from 1<sup>st</sup> January 2021 to 30<sup>th</sup> June 2023. All blood cultures received from different departments of the hospital were included. The 2.5-year study period was divided into pre-intervention and intervention periods, with monthly monitoring of BCC. The BCC data between 1<sup>st</sup> January 2021 and 31<sup>st</sup> December 2021 was taken as the baseline pre-intervention period and the next 1.5 years comprised the intervention period (1<sup>st</sup> January 2022-30<sup>th</sup> June 2023). To improve compliance, various strategies were implemented, such as regular training sessions, didactic sessions, and re-competencies.</p><p><strong>Results: </strong>A total of 86 774 Blood cultures were received from all departments of the hospital, out of which n = 30 672 were received in the pre-intervention period whereas, n = 56 102 were received in the intervention period. Mean BCC rate in the pre-intervention period was found to be 4.6%. However, after the implementation of different measures to reduce BCC, the contamination rate decreased to a mean of 3.1% by the end of the intervention period. Emergency department accounted for the highest proportion of BCC in the pre-intervention and intervention periods.</p><p><strong>Conclusion: </strong>We decreased BCC in our tertiary care setup by implementing a simple and inexpensive collaborative intervention, and came to the conclusion that the higher incidence of BCC was probably caused by factors unique to the emergency department and provided measures to successfully address them.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241265857"},"PeriodicalIF":1.9,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Diagnostic Perplexity in Primary Pelvic Hydatid Disease, Mimicking Tumor and Tuberculosis: A Case Report.","authors":"Sweta Bahadure, Anand Hatgaonkar, Nandkishor Bankar, Tejas Sadavarte, Yugeshwari Tiwade, Avinash Rinait","doi":"10.1177/2632010X241253232","DOIUrl":"10.1177/2632010X241253232","url":null,"abstract":"<p><p>The differential diagnosis of cystic echinococcosis should be considered in the suspected case of a pelvic mass presenting with vague symptoms. Primary pelvic hydatid cyst is rare, and the achievement of early diagnosis is important, as the involvement of bone in the pelvis is difficult to treat, and the probability of recurrences is greater. This case report presents a rare case of a primary pelvic hydatid cyst in a male in his 30s. The patient presented vague symptoms of difficulty in micturition and chronic pelvic pain. First-line radiological imaging techniques diagnosed it as a neoplastic mass and tuberculosis, while MRI revealed it as a cystic disease, probably a hydatid cyst. Surgical excision and histopathological examination confirmed the diagnosis of a primary pelvic hydatid cyst. Acquaintance with the varied presentation of cystic echinococcosis helps to obtain an accurate diagnosis and thus decreases the severe complication associated with the disease. This case report highlights the importance of considering parasitic infections in the differential diagnosis of cystic pelvic masses, even in regions with low endemicity.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241253232"},"PeriodicalIF":1.9,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PathologyPub Date : 2024-06-10eCollection Date: 2024-01-01DOI: 10.1177/2632010X241260200
Jad Hosri, Yara Yammine, Nadine El Hadi, Jessica Aoun, Marc Mourad, Usamah Hadi
{"title":"Intramuscular Lipoma of the Sternocleidomastoid Muscle: A Rare Entity Revisited.","authors":"Jad Hosri, Yara Yammine, Nadine El Hadi, Jessica Aoun, Marc Mourad, Usamah Hadi","doi":"10.1177/2632010X241260200","DOIUrl":"10.1177/2632010X241260200","url":null,"abstract":"<p><p>Intramuscular lipomas, typically found in subcutaneous tissue, rarely affect deeper muscular planes, especially those of the head and neck region. The following are 3 cases of intramuscular lipomas involving the sternocleidomastoid muscle. The first 2 patients presented with painless, palpable masses confirmed by diagnostic imaging as well-circumscribed intramuscular lipomas. One was treated surgically, while the other was managed conservatively with monitoring and close follow-up. The third patient reported dysphagia associated with occasional dyspnea and mild pain. The mass was identified as infiltrative lipoma and was resected surgically. Complete tumor removal with no recurrence at 6 months was observed for the first and last cases. The second case was serially followed at 3 and 6 months with no interval changes. We report the largest case series on intramuscular lipomas of the sternocleidomastoid muscle to enhance our understanding of this rare entity.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241260200"},"PeriodicalIF":1.3,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11165958/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Seborrheic Keratosis: Report of a Rare Presentation and Reminder of the Current Knowledge of the Problem.","authors":"Bahaeddine Lahbacha, Salwa Nechi, Abir Chaabane, Amina Bani, Majdi Kchaou, Fadhel Chtourou, Mohamed Karim Mfarrej, Amel Douggaz, Emna Chelbi","doi":"10.1177/2632010X241255874","DOIUrl":"10.1177/2632010X241255874","url":null,"abstract":"<p><p>A 75-year-old man presented with an abdominal enlarging painless tumor of the skin evolving over the last 30 years. His past medical history was unremarkable. Physical examination revealed a brownish pedunculated cutaneous mass which had an irregular keratotic warty surface with no discharge or ulceration. The mass was clinically presumed to be a melanocytic tumor, or a verrucous carcinoma. A monoblock excision of the mass was performed with a good outcome. The specimen was then sent to our pathology department to rule out malignancy. Macroscopic examination revealed a brownish tumor of 7.5 × 7 × 1.5 cm which had fissures and cauliflower-like appearance. Final histological report concluded to a giant seborrheic keratosis.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241255874"},"PeriodicalIF":1.3,"publicationDate":"2024-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11128169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PathologyPub Date : 2024-05-14eCollection Date: 2024-01-01DOI: 10.1177/2632010X241254961
Proma Rani Das, Sakif Ahamed Khan, Mohammad Safiqul Islam, Syed Masudur Rahman Dewan
{"title":"Public Health Emergence: Challenges and Prospects for the Future of Herd Immunity to Reduce the Negative Impact of Disease X in Low- and Middle-Income Countries.","authors":"Proma Rani Das, Sakif Ahamed Khan, Mohammad Safiqul Islam, Syed Masudur Rahman Dewan","doi":"10.1177/2632010X241254961","DOIUrl":"10.1177/2632010X241254961","url":null,"abstract":"","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241254961"},"PeriodicalIF":1.3,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11092528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140923830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PathologyPub Date : 2024-04-19eCollection Date: 2024-01-01DOI: 10.1177/2632010X241248909
Phu Cuong Pham, Hoang Anh Thi Van, Van Trung Hoang, The Huan Hoang, Duc Duy Nguyen, Duc Thanh Hoang
{"title":"Appendiceal Diverticulitis Mimics Cecal Diverticulitis Diagnosed Preoperatively.","authors":"Phu Cuong Pham, Hoang Anh Thi Van, Van Trung Hoang, The Huan Hoang, Duc Duy Nguyen, Duc Thanh Hoang","doi":"10.1177/2632010X241248909","DOIUrl":"https://doi.org/10.1177/2632010X241248909","url":null,"abstract":"<p><p>Appendiceal diverticulitis is an uncommon condition that clinically resembles acute appendicitis. However, it is an incidental finding in histopathological studies and is rarely diagnosed preoperatively by imaging studies. In this article, we present the clinical and imaging findings of a male patient presenting with right upper quadrant pain with a preoperative imaging diagnosis of appendiceal diverticulitis. He underwent laparoscopic appendectomy and confirmed the diagnosis of appendiceal diverticulitis. This is a rare preoperative diagnosis. The management is often like typical appendicitis which is appendectomy. It is important to differentiate it from diverticulitis of the small intestine or colon because these diseases usually require only conservative treatment.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241248909"},"PeriodicalIF":1.3,"publicationDate":"2024-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recurrent Adamantinoma With Fibrous Dysplasia-like Feature.","authors":"Anja Petaros, Veljko Šantić, Anita Savić Vuković, Petar Perić, Nives Jonjić","doi":"10.1177/2632010X241240391","DOIUrl":"https://doi.org/10.1177/2632010X241240391","url":null,"abstract":"<p><p>Adamantinoma (AD) is a rare, slow-growing primary malignant bone tumor characterized by a biphasic morphology of clusters of epithelial cells and spindle cell osteofibrous components. A strong relationship between AD and osteofibrous dysplasia (OFD) has been proposed, while fibrous dysplasia (FD) has been rarely associated with AD. We present an AD case that was followed and histologically evaluated 3 times over 6 years with different morphological patterns. The tumor in the primary biopsy and after complete resection showed classical features of AD and osteofibrous-like pattern, while the recurrent lesion presented with exclusively spindle cell morphology and was thus diagnosed as FD. However, the extensive immunohistochemical analysis in all 3 lesions revealed strong reactivity for pancytokeratin, vimentin, p63, and podoplanin, which are characteristic for AD. Although, in the FD-like section of the tumor from the first recurrence the positivity of podoplanin was stronger than pancitokeratin, which was variably positive on spindle cells. The present case highlights the problem of diagnosing AD based on a single biopsy with one tumor's component predominating over the other, and at the same time emphasizes the importance of using immunohistochemical staining for keratin and podoplanin when the histopathological features of (osteo)fibrous lesion can be linked to AD.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241240391"},"PeriodicalIF":1.3,"publicationDate":"2024-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11003218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140870347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Relationship Between Tumor Budding and Patient's Survival in Breast Cancer.","authors":"Mohammad Ranaee, Hossein Torabi, Narges Azhganzad, Kasra Shirini, Akram Sadat Hosseini, Karimollah Hajian","doi":"10.1177/2632010X241235543","DOIUrl":"10.1177/2632010X241235543","url":null,"abstract":"<p><strong>Introduction: </strong>Breast cancer is a severe life-threatening condition in which many women are involved yearly. One factor that has recently been noticed and investigated as a diagnostic predictor of this type of cancer is the number of tumor buds and the relation of this factor with a patient's survival rate.</p><p><strong>Materials and methods: </strong>This study includes 150 female patients over 18 years old with a mean age of 53.99 ± 12.56 years old with breast cancer, which was diagnosed at various medical centers, including Rouhani Hospital itself, and referred to Rouhani Hospital Medical Center, Babol, Iran. The number of intratumoral and peritumoral buds in patients' microscopic slides were archived and evaluated along with tumor microenvironment on hematoxylin and eosin (H&E) slides and compared to other clinicopathological findings. This article precisely investigated the relationship between the number of intratumoral and peritumoral buds with patients' 5-year survival rate. Also, the relationship between age, tumor stage, grade, size, the number of lymph nodes involved, and the presence of metastasis with the number of intratumoral and peritumoral buds was studied.</p><p><strong>Results and discussion: </strong>The result showed a significant statistical association between the number of intratumoral and peritumoral buds with tumor size, tumor stage, presence of metastasis, the number of lymph nodes involved, and 5-year survival rate. On the other hand, there is not a significant statistical association between the number of intratumoral and peritumoral buds with age and tumor grade.</p><p><strong>Conclusion: </strong>Our investigation revealed a significant statistical relationship between the number of tumor buds and patients' survival rate. So, this factor should be considered significant to help those patients increase their survival ratio.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241235543"},"PeriodicalIF":1.3,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140133206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Clinical PathologyPub Date : 2024-02-18eCollection Date: 2024-01-01DOI: 10.1177/2632010X241232302
Kirill E Medvedev, Paul H Acosta, Liwei Jia, Nick V Grishin
{"title":"Deep Learning for Subtypes Identification of Pure Seminoma of the Testis.","authors":"Kirill E Medvedev, Paul H Acosta, Liwei Jia, Nick V Grishin","doi":"10.1177/2632010X241232302","DOIUrl":"10.1177/2632010X241232302","url":null,"abstract":"<p><p>The most critical step in the clinical diagnosis workflow is the pathological evaluation of each tumor sample. Deep learning is a powerful approach that is widely used to enhance diagnostic accuracy and streamline the diagnosis process. In our previous study using omics data, we identified 2 distinct subtypes of pure seminoma. Seminoma is the most common histological type of testicular germ cell tumors (TGCTs). Here we developed a deep learning decision making tool for the identification of seminoma subtypes using histopathological slides. We used all available slides for pure seminoma samples from The Cancer Genome Atlas (TCGA). The developed model showed an area under the ROC curve of 0.896. Our model not only confirms the presence of 2 distinct subtypes within pure seminoma but also unveils the presence of morphological differences between them that are imperceptible to the human eye.</p>","PeriodicalId":53204,"journal":{"name":"Clinical Pathology","volume":"17 ","pages":"2632010X241232302"},"PeriodicalIF":1.3,"publicationDate":"2024-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10878207/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139914052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}